United States November 2014 Supplement

Table of Contents

Supplement

The Rise of Peripheral Drug Elution

How to incorporate drug-coated balloons and drug-eluting stents into your practice.

In This Supplement

Download PDF

Drug Elution, Data, and Decisions

What the data tell us about how to integrate drug-eluting technology into our daily practice.

By Gary Ansel, MD, and John A. Phillips, MD

An Overview of Superficial Femoral Artery Stenting

The history, data, and latest advancements in stenting of the SFA and popliteal arteries.

By John R. Laird, MD, and Ehrin J. Armstrong, MD

Zilver PTX for Simple and Challenging Lesions

How I integrate this versatile tool into my lower extremity practice.

By William A. Gray, MD

DCBs in the United States

The use of drug-coated balloons is creating a paradigm shift in the treatment of peripheral arterial disease by preventing restenosis and leaving nothing behind.

By George L. Adams, MD, MHS, and O Jesse Mendes, BA

DES and DEB Use in Europe

As devices develop and longer follow-up data become available, one thing is certain: It's a drug-eluting world, all right.

By Konstantinos Katsanos, MSc, MD, PhD, EBIR

The Costs and Benefits of Medical Innovation

Looking beyond prices and assessing the true value of new technologies.

By Louis L. Nguyen, MD, MBA, MPH, and Rebecca E. Scully, MD

DES Versus Bypass for Femoropopliteal Disease

Should the current data on drug-eluting devices cause surgeons to reconsider when to use bypass?

By Marc Bosiers, MD, and Koen Deloose, MD

Latest Issues

April 2026

March 2026

February 2026

January 2026

December 2025

View All Issues

In This Supplement

Most Read Articles